Nexalin Technology (NXL) Revenue (QoQ) (2021 - 2026)
Nexalin Technology (NXL) Revenue (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Nexalin Technology | 9.07 Mn | 6.36 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.30% |
| Dec 31, 2025 | 847.13% |
| Sep 30, 2025 | -74.29% |
| Jun 30, 2025 | 72.10% |
| Mar 31, 2025 | 50.91% |
| Dec 31, 2024 | -24.57% |
| Sep 30, 2024 | 34.24% |
| Jun 30, 2024 | -65.88% |
| Mar 31, 2024 | 283.09% |
| Dec 31, 2023 | -14.83% |
| Sep 30, 2023 | -32.15% |
| Jun 30, 2023 | 16.30% |
| Mar 31, 2023 | -20.47% |
| Dec 31, 2022 | -92.95% |
| Sep 30, 2022 | 31.63% |
| Jun 30, 2022 | 28.13% |
| Mar 31, 2022 | 1,247.23% |
| Dec 31, 2021 | -57.12% |